pseudoscience in healthcare Archives - Everyday Software, Everyday Joyhttps://business-service.2software.net/tag/pseudoscience-in-healthcare/Software That Makes Life FunSat, 14 Feb 2026 09:32:08 +0000en-UShourly1https://wordpress.org/?v=6.8.3The regulation of nonsensehttps://business-service.2software.net/the-regulation-of-nonsense/https://business-service.2software.net/the-regulation-of-nonsense/#respondSat, 14 Feb 2026 09:32:08 +0000https://business-service.2software.net/?p=6637Licensing crystal healers and miracle supplements might sound like consumer protection, but when the law blesses unproven treatments, patients struggle to tell the difference between science-based care and beautifully packaged nonsense. This deep dive unpacks how U.S. rules for supplements, homeopathy, and other alternative therapies actually work, why regulators struggle to keep up, and what a truly evidence-based approach to protecting patients would look like.

The post The regulation of nonsense appeared first on Everyday Software, Everyday Joy.

]]>
.ap-toc{border:1px solid #e5e5e5;border-radius:8px;margin:14px 0;}.ap-toc summary{cursor:pointer;padding:12px;font-weight:700;list-style:none;}.ap-toc summary::-webkit-details-marker{display:none;}.ap-toc .ap-toc-body{padding:0 12px 12px 12px;}.ap-toc .ap-toc-toggle{font-weight:400;font-size:90%;opacity:.8;margin-left:6px;}.ap-toc .ap-toc-hide{display:none;}.ap-toc[open] .ap-toc-show{display:none;}.ap-toc[open] .ap-toc-hide{display:inline;}
Table of Contents >> Show >> Hide

Every few months, a well-meaning lawmaker somewhere in the United States wakes up and says,
“We really ought to regulate this alternative medicine stuff.” Task forces are formed,
hearings are held, and suddenly there’s a brand-new bill to license crystal whisperers,
detox foot-bath technicians, and people who sell supplements that promise to “optimize”
anything that sits still long enough.

On the surface, this sounds reassuring. Regulation feels like order. Licenses and official
boards sound like protection. But there’s a problem that science-based clinicians have been
pointing out for years: when you formally regulate nonsense, what you mostly succeed in doing
is blessing nonsense. The public sees something wrapped in legal language and assumes
it has been vetted by science, not just by lobbyists.

In other words, the regulation of nonsense tends to create regulated nonsense. And that is
not what evidence-based healthcare is supposed to look like.

What do we mean by “nonsense” in medicine?

In everyday life, “nonsense” might mean a weird family superstition or your coworker’s
conspiracy theory about printer paper. In medicine, the word is narrower and much more
serious. Here, we’re talking about health interventions that:

  • Are not backed by credible, reproducible evidence
  • Often contradict well-established principles of biology, chemistry, or physics
  • Are marketed using emotional stories instead of solid data
  • Sometimes directly conflict with effective, life-saving care

That includes a wide range of practices and products often lumped under the “complementary
and alternative medicine” (CAM) umbrella: homeopathy that dilutes ingredients past the point
where any molecules remain, “energy medicine” that adjusts unmeasurable, undefined fields,
supplements that claim to cure multiple unrelated diseases, and detox regimens that never
quite specify the toxin.

The key point isn’t whether a therapy feels traditional, natural, or comforting. The key
point is whether it works better than placebo and is reasonably safe. When therapies fail
those basic tests, trying to regulate them the same way we regulate genuine medical
interventions creates a tangle of risk, confusion, and unintended consequences.

The strange logic of licensing pseudoscience

One of the central arguments from science-based critics is simple: if you create a licensing
system for a practice that is not grounded in reality, you inevitably end up with rules that
entrench that unreality. You can’t write a law about which herbs “balance energy channels”
without first pretending that such channels exist.

Licensing boards for pseudoscientific professions tend to focus on internal coherence
(“Did you follow the rules of this belief system?”) rather than actual medical outcomes.
A homeopath can be disciplined for using the “wrong remedy” under the doctrine of
homeopathy but not for the fact that high-quality trials consistently fail to show that
homeopathic remedies perform better than placebos.

From the outside, though, the public rarely sees that nuance. They just see:

  • A state board
  • A license hanging on the wall
  • A title that sounds medical-ish

Combine that with white coats, stethoscopes, and a website full of wellness buzzwords, and
it becomes almost impossible for a non-expert to distinguish between science-based medicine
and a regulated system of elaborate placebos.

Why the U.S. regulatory patchwork invites nonsense

To really appreciate how nonsense sneaks into the system, you have to understand that
healthcare in the United States is governed by a patchwork of overlapping rules and
agencies:

  • Federal agencies such as the Food and Drug Administration (FDA) and
    Federal Trade Commission (FTC) oversee products, labeling, and advertising claims.
  • State governments license professionals and define scopes of practice.
  • Legislatures can carve out special exceptions for certain industries
    and traditions.

Decades of lobbying by the supplement and CAM industries have created generous carve-outs
that let many products onto the market with minimal premarket scrutiny. Under the
Dietary Supplement Health and Education Act (DSHEA), for example, most supplements do not
require FDA approval before they are sold, and the burden of proof is often shifted to the
government to act after harm occurs rather than before the product launches.

At the same time, states have created licensure for a range of non-physician practitioners,
sometimes based more on political compromise than on evidence of efficacy. Once those
practice acts are in place, rolling them back is politically painful. No one wants to be
accused of “taking away people’s choices,” even if the choice in question is between
chemotherapy and a smoothie cleanse.

How pseudoscience leverages the language of regulation

Industries that rely on weak evidence have learned to speak fluent regulator-ese. You’ll
see phrases like:

  • “Complies with all applicable FDA regulations”
  • “Manufactured in an FDA-registered facility”
  • “Meets current Good Manufacturing Practices (cGMP)”

None of those statements mean the product has been tested and proven to do what the label
claims. They mostly describe how the product is made and labeled, not whether it
works. A beautifully labeled sugar pill is still a sugar pill.

Even disclaimers can be weaponized. You’ve probably seen the classic supplement disclaimer:
“This statement has not been evaluated by the Food and Drug Administration. This product
is not intended to diagnose, treat, cure, or prevent any disease.” It appears in tiny text
under a giant promise to boost immunity, rejuvenate your brain, or reverse aging.

For science-literate readers, the disclaimer is a warning. For everyone else, it’s just
legal wallpaper behind a glossy lifestyle fantasy.

The FTC, FDA, and the slow battle against health scams

Thankfully, the system is not completely asleep at the wheel. The FTC regularly brings
cases against companies that make blatantly deceptive health claims, from miracle weight
loss pills to devices that promised to prevent COVID-19 with almost no evidence behind
them. The bar, at least in theory, is that health claims must be supported by “competent
and reliable scientific evidence.”

In parallel, the FDA has updated its approach to homeopathic products and certain CAM
therapies, moving away from a hands-off stance toward prioritizing enforcement against
higher-risk productsthose that make serious disease treatment claims, target vulnerable
populations, or contain potentially unsafe ingredients.

But enforcement is resource-intensive, and the marketplace of nonsense is endlessly
inventive. For every product the agencies manage to challenge, dozens more pop up with
slightly tweaked wording, fresh branding, or a different “natural” angle.

Why the current system still falls short

From a science-based medicine perspective, the core problem isn’t that regulators never act.
It’s that the default posture of the law is not “prove it works before you sell it,” but
“sell it until someone proves it’s harmful or misleading.” That asymmetry favors nonsense
by design.

Add in the communication challengeagencies publishing careful, technical guidance while
marketers publish eye-catching TikToksand you have a playing field that is tilted heavily
toward those willing to stretch the truth.

Medical freedom vs. consumer protection: the rhetorical trap

There is a powerful rhetorical move that defenders of pseudoscientific products use over and
over: they frame any attempt to tighten evidence standards as an attack on “health freedom.”
Smart regulation is recast as a tyrannical attempt to control what people put in their own
bodies.

This is emotionally compelling but logically confused. Science-based regulation does not
dictate which choices individuals make. It sets a reasonable floor for honesty:

  • If you claim to prevent disease, you should actually be able to prevent disease.
  • If you claim to cure a condition, your product should outperform placebo in good trials.
  • If you sell something with real risks, those risks should be clearly disclosed.

Requiring evidence is not an assault on freedom; it is a defense of people’s right not to
be misled when they are scared, sick, or desperate. Pseudoscience thrives precisely when
people are most vulnerable and least able to critically evaluate what they’re being sold.

What a science-based regulatory framework would actually look like

If we took science-based medicine seriously as the guiding principle, regulation would look
very different from the current mix of loopholes, special categories, and euphemistic
disclaimers. A more rational framework might include:

1. One evidence standard for all health claims

Whether a product is labeled as a “drug,” “supplement,” “natural remedy,” or “traditional
formula,” the same core rule would apply: if you make a specific health claim, you need
solid evidence to back it up. Not testimonials, not cherry-picked in vitro studies, but
credible clinical data that would satisfy a skeptical, independent expert.

2. Transparency by default

Labels and ads should clearly state what is known and what is not. If evidence is
weak, preliminary, or contradictory, that should be communicated in plain language. If no
clinical trials exist, that should be explicit rather than hidden behind vague phrases like
“traditionally used for.”

3. No special carve-outs for magical thinking

Laws should not codify concepts with no basis in reality, such as “balancing life energy”
or “correcting quantum vibrations” of organs. People are free to believe in those ideas on
their own time, but they shouldn’t be embedded into professional practice acts or used to
shield purveyors from normal evidence requirements.

4. Proactive protection for high-risk situations

Regulators should prioritize interventions that:

  • Claim to treat serious diseases (cancer, heart disease, diabetes, neurodegenerative conditions)
  • Target children, older adults, or other vulnerable populations
  • Encourage people to delay or abandon proven treatments

In those settings, even “low-risk” nonsense is not benign, because the main harm is not the
sugar pill itself; it’s the opportunity cost of lost time and neglected real care.

What individuals can do while the system catches up

While we wait for lawmakers to grow spines and regulatory frameworks to catch up with
reality, individual patients and families still have to navigate the maze. A few practical
filters can help:

  • Be suspicious of big promises. If something claims to cure everything
    from arthritis to Alzheimer’s, it probably does none of those things.
  • Look for real evidence, not just stories. Stories can be comforting, but
    they are not a substitute for controlled trials.
  • Ask who benefits if you believe this. Is someone selling you an expensive
    product or long-term treatment plan?
  • Talk to a science-literate clinician. A good doctor, pharmacist, or other
    evidence-based professional should be able to help you weigh risks and benefits honestly.

You don’t need to become an expert epidemiologist to protect yourself. You just need a
healthy skepticism, a willingness to ask hard questions, and an understanding that the
phrase “all-natural” has no magical powers.

Experiences from the front lines of regulating nonsense

The debate over the regulation of nonsense is not just an abstract legal puzzle. It plays
out in clinics, pharmacies, board meetings, and kitchen tables every day. Here are some
composite scenariosdrawn from how these issues typically appear in real lifethat show
what’s at stake.

The oncologist and the “licensed” alternative clinic

Imagine an oncologist meeting a new patient with advanced cancer. The patient has spent the
last year visiting a licensed alternative clinic that offers vitamin infusions, “immune
boosting” injections, and high-priced detox plans. The clinic is state-licensed, the staff
wear white coats, and the waiting room has a wall of framed certificates.

From the patient’s perspective, this looked legitimateafter all, the practitioners had
official titles and regulatory approval. But the treatments, while emotionally comforting,
had no meaningful impact on the cancer. Valuable time was lost, and by the time evidence-based
care begins, the window for cure has narrowed.

The oncologist’s anger is not directed at the patient, but at a system that licensed a set
of practices whose foundational claims were never held to scientific standards. Regulation
in this case did not protect; it camouflaged the problem.

The pharmacist and the supplement aisle

In many large U.S. pharmacies, the supplement aisle looks almost indistinguishable from the
prescription counter. Bottles are color-coordinated, labels are polished, and health claims
hover right on the line between implication and explicit promise.

Pharmacists routinely field questions like, “This says it supports joint healthdoes it
actually work?” or “Is this homeopathic cold medicine okay for my toddler?” The awkward
reality is that many of these products are on the shelves not because they cleared a
rigorous evidence bar, but because they fall into regulatory categories that require far
less proof.

Some pharmacists print out summaries of the evidence, others steer people gently back toward
treatments with proven benefit, and some simply shrug under the weight of time pressure.
The mismatch between how “official” these products look and how little we actually know
about their effectiveness is a daily reminder of how partial our regulation really is.

The regulator trying to prioritize real harm

Regulators themselves are often acutely aware of these limitations. Picture a career staffer
at a federal agency reviewing complaints: there are miracle cancer cures advertised online,
weight loss teas linked to liver injury, and a company selling homeopathic remedies for
infants with vague claims about “supporting respiratory wellness.”

With limited staff and legal constraints, the regulator has to choose where to spend their
enforcement capital. They know that going after one particularly egregious scam may send an
important signal, but they also know that thousands of smaller nonsense claims will persist
unchallenged simply because the law wasn’t written to demand proof before such
products flood the market.

It is frustrating work: trying to use a leaky bucket to bail out a boat that someone
keeps drilling new holes into.

The patient caught between hope and skepticism

Finally, there is the person at the center of all this: the patient. Maybe they’ve just
received a new diagnosis. Maybe conventional treatment helped but didn’t fully resolve
their symptoms. Maybe they feel dismissed or rushed by a healthcare system that is
overstretched and under-empathetic.

Then they encounter a regulated alternative practitioner who spends an hour listening,
nodding, and offering a tidy explanation for every symptom based on energy, toxins,
imbalances, or a handful of lab tests of dubious value. It feels human and attentive in a
way that many mainstream encounters do not.

From this vantage point, the fact that the practitioner is licensed, or the supplement is
sold in a chain pharmacy, seals the deal. Regulation has done what good branding alone
could never do: it has conferred a sense of institutional trust. The patient is not being
foolish; they are responding to cues the system itself created.

This is why science-based medicine argues that the only honest way forward is to align our
regulatory signals with reality. Licensure, shelf placement, and advertising rules should
all point in the same direction: toward interventions that are grounded in good evidence
and away from those that are mostly storytelling wrapped in legal disclaimers.

Conclusion: regulating for reality, not rhetoric

The regulation of nonsense is one of the most quietly consequential issues in modern
healthcare. It shapes what patients see in pharmacies, what they hear in clinics, and how
they interpret the difference between a science-based treatment and a promising story with
no data behind it.

If we license pseudoscience as if it were medicine, the public will, quite reasonably,
treat it as medicine. If we give health products a free pass on evidence as long as they
wear the right marketing language, nonsense will continue to flourish in the gaps between
law and science.

A genuinely science-based regulatory system would be more boring, more demanding, and far
less friendly to magical thinking. It would also be more honest. And when people’s health,
savings, and time are on the line, honesty is the least the system can offer.

The post The regulation of nonsense appeared first on Everyday Software, Everyday Joy.

]]>
https://business-service.2software.net/the-regulation-of-nonsense/feed/0
CARA: Integrating even more pseudoscience into veterans’ healthcarehttps://business-service.2software.net/cara-integrating-even-more-pseudoscience-into-veterans-healthcare/https://business-service.2software.net/cara-integrating-even-more-pseudoscience-into-veterans-healthcare/#respondFri, 06 Feb 2026 01:40:12 +0000https://business-service.2software.net/?p=4662CARA pushed the VA to expand complementary and integrative health (CIH) serviceseverything from yoga and acupuncture to broader, sometimes vague “wellness” concepts. That can be a win for veterans dealing with chronic pain and mental health challenges, especially as U.S. guidance increasingly supports multimodal, nonpharmacologic care. But CARA’s broad language also raises a real risk: mixing evidence-backed approaches with therapies that are unproven, oversold, or scientifically implausible. This article breaks down what CARA requires, which CIH options have credible support, how the VA’s own policies build guardrails (CIH as a complement, not a replacement), and what it takes to integrate new options without funding pseudoscience. If the goal is better outcomes for veterans, the path forward is clear: measure what matters, credential providers, and be willing to drop interventions that don’t deliver.

The post CARA: Integrating even more pseudoscience into veterans’ healthcare appeared first on Everyday Software, Everyday Joy.

]]>
.ap-toc{border:1px solid #e5e5e5;border-radius:8px;margin:14px 0;}.ap-toc summary{cursor:pointer;padding:12px;font-weight:700;list-style:none;}.ap-toc summary::-webkit-details-marker{display:none;}.ap-toc .ap-toc-body{padding:0 12px 12px 12px;}.ap-toc .ap-toc-toggle{font-weight:400;font-size:90%;opacity:.8;margin-left:6px;}.ap-toc .ap-toc-hide{display:none;}.ap-toc[open] .ap-toc-show{display:none;}.ap-toc[open] .ap-toc-hide{display:inline;}
Table of Contents >> Show >> Hide

Every few years, Congress hands the Department of Veterans Affairs (VA) a new mission with a name that sounds like a
Marvel side quest. In 2016, that mission arrived as CARAthe Comprehensive Addiction and Recovery Act. On its face,
CARA is about substance use disorder prevention, treatment, and recovery. But tucked inside its VA-focused sections is a
very different storyline: expand “complementary and integrative health” (CIH) inside veterans’ care.[1]

That sounds wholesomewho doesn’t want veterans to have more options than “here’s a pill, good luck”? The complication is
that CIH is a big umbrella. Under it you’ll find practices with decent evidence (like certain mind-body therapies for pain),
alongside ideas that range from “unproven” to “implausible” to “this was invented in a strip-mall office with a salt lamp.”
CARA doesn’t cleanly separate those categories. It accelerates integration, while the VA then has to build guardrails fast
enough to keep “more options” from becoming “more nonsense.”[2]

What CARA actually asks the VA to do

The most quoted CIH-related piece is a section that lays out a sweeping VA plan: within 180 days, develop a strategy to
materially and substantially expand research, education, and delivery/integration of complementary and integrative health
services across VA care.[3] This isn’t just “allow yoga in the rec room.” It’s an instruction to build infrastructure:
research priorities, training for VA clinicians, and metrics to measure whether any of this works.[3]

CARA also pushes the VA toward pilots and evaluation. The idea is to test whether CIH and wellness-based programs can
complement pain management and related services (including mental health care), and then report outcomes and barriers.[4]
The intentreduce suffering, improve function, and avoid overreliance on high-risk medicationsmakes sense in the context of
the opioid crisis and chronic pain burden.

The “COVER Commission” and the problem with open-ended lists

Here’s where the pseudoscience anxiety kicks in. In the VA portions of CARA, Congress calls for a commission to examine
VA’s evidence-based therapy model for mental health conditions and explore the potential benefits of incorporating CIH as
standard practice.[1] The commission is asked to review a list of therapies that reads like a cross between a wellness
brochure and a late-night infomercial: music therapy, equine therapy, service dogs, yoga therapy, acupuncture therapy,
meditation therapy, outdoor sports therapy, hyperbaric oxygen therapy, accelerated resolution therapy, art therapy, and
“magnetic resonance therapy”plus “other therapies the Commission determines appropriate.”[1]

Some items on that list are mainstream-adjacent or clearly “reasonable to study.” Yoga and meditation have plausible
mechanisms and growing evidence for certain outcomes. Service dogs can be profoundly meaningful for some veterans’ daily
function. But several entries are either (a) condition-specific and controversial (hyperbaric oxygen for certain mental health
claims), (b) ambiguous in the way legislative language can be (“magnetic resonance therapy” can be interpreted multiple ways),
or (c) so broad that the phrase “other therapies” becomes a gateway to… well, anything with a lobbyist and a brochure.
That’s not how you build an evidence hierarchy; it’s how you build a buffet line.[1]

CARA does include a couple of “please don’t make this a cash grab” protections: the commission’s members are supposed to be
of recognized standing with experience treating mental health and working with military/veteran populations, and they should
not have a financial interest in the therapies being reviewed.[1] That’s helpfulbut it doesn’t automatically sort
strong evidence from weak evidence, or plausibility from magical thinking.

Why CIH became attractive policy in the first place

To understand why CIH gained momentum, you have to remember what veterans’ health systems were trying to solve: chronic pain,
trauma-related conditions, sleep problems, anxiety, depression, and functional impairmentoften overlapping in the same person.
In that landscape, “one medication at a time” can snowball into polypharmacy, side effects, dependence, and disappointment.

Major public health guidance in the U.S. has increasingly emphasized multimodal pain care and the value of nonpharmacologic
options. The CDC’s 2022 opioid prescribing guideline points out that multiple noninvasive nonpharmacologic interventions can
improve chronic pain and function with small-to-moderate effects in specific conditions, generally without serious harmsand
it explicitly discusses approaches like acupuncture, massage, mindfulness-based interventions, tai chi, and yoga in the
broader context of pain management.[5]

The National Center for Complementary and Integrative Health (NCCIH, part of NIH) also describes a reality clinicians already
live with: many complementary approaches show modest benefits, the evidence quality varies widely by condition, and
guidelines from mainstream professional organizations increasingly include certain complementary optionsespecially for
chronic low-back pain and other musculoskeletal problems.[6]

Evidence check: what’s solid, what’s “maybe,” and what’s wishcasting

A useful way to think about CIH is to sort it into three buckets: supported, promising but limited,
and implausible/unsupported. CARA doesn’t do this sorting for youso the VA (and clinicians) have to.

Bucket 1: Supported enough to be in real guidelines

For chronic low-back pain, professional guidelines have encouraged nonpharmacologic first-line treatments that include options
such as acupuncture, mindfulness-based stress reduction, tai chi, yoga, progressive relaxation, biofeedback, and spinal
manipulationalongside conventional approaches like exercise and cognitive behavioral therapy.[6] That doesn’t mean
these methods are miracle cures; it means they’re reasonable tools, with benefits that may be meaningful to some patients and
generally low risk when delivered appropriately.

NCCIH’s summaries are blunt in a very science-y way: effects are often small to moderate, and the quality/amount of evidence
varies by condition and intervention.[7] But “small” can still matter if it helps someone sleep, move, and function
without escalating medication risk.

Bucket 2: Promising, but easily oversold

Acupuncture is a good example of “promising but frequently oversold.” NCCIH notes evidence for certain painful conditions,
including findings where acupuncture outperformed no treatment and sometimes sham acupuncture, with benefits that can persist
after treatmentwhile also showing that effect sizes and certainty vary by condition and study design.[8] Translation:
it may help, especially for some pain syndromes, but it’s not a universal remote for the nervous system.

Yoga is similar: evidence suggests it can improve pain and function for chronic low-back pain, sometimes with effects similar
to exercise, and it may help related issues like distress and sleep for some people. But it’s not automatically superior to
physical therapy, and outcomes depend on the program, adherence, and patient fit.[9]

Bucket 3: Implausible/unsupported (a.k.a. “please don’t bill the VA for vibes”)

This is where the word “pseudoscience” earns its keep. The more a therapy relies on claims that contradict basic biology
(“memory water,” invisible energy fields that only the practitioner can sense, detox pathways that don’t exist), the higher
the evidentiary bar should bebecause extraordinary claims require extraordinary evidence. CARA’s open-ended language (“other
therapies”) creates a risk: once a health system publicly commits to “integrating CIH,” vendors of dubious modalities can
argue they deserve a seat at the table.[1]

It’s also easy to confuse “low risk” with “worth funding.” A therapy might be physically safe but still waste resources if it
crowds out evidence-based care, delays effective treatment, or drains budgets that could have paid for more mental health
clinicians, physical therapists, or pain psychologists.

The VA’s guardrails: how it tries to integrate CIH without abandoning science

Whatever critics fear Congress might accidentally unleash, the VA has tried to define CIH in a controlled, policy-driven way.
In its directive governing CIH approaches, the VA states clearly that CIH must be offered as a complement to
conventional carenot as an alternativeand that appropriateness is still a clinical judgment with contraindications and
patient preferences in view.[10]

The same directive also defines a required list of CIH approaches that must be made available across the VA
health care system (through VA facilities or community networks): acupuncture, biofeedback, clinical hypnosis, guided imagery,
massage therapy, meditation, tai chi/qigong, and yoga.[11] Notice what’s missing: homeopathy, “energy healing,”
detox regimens, and other high-implausibility greatest hits.

Even the required list comes with caveats: the VA describes the list as guidance, emphasizes evidence alongside conventional
care, and notes the list can evolvemodalities can become conventional over time or be removed later based on emerging
evidence and practice changes.[12] That is what a science-aligned system should do: treat the benefits package as a
living document.

So… is CARA integrating pseudoscience, or integrating options?

The honest answer is: it depends on implementation. CARA’s language pushes expansion and exploration. That
can be good when it funds pragmatic research, clinician training, and careful measurement. It’s risky when it treats “CIH”
like a brand identitysomething you adopt to appear progressiverather than a set of interventions that must individually
earn their place.

Critics have argued that CARA’s VA provisions create a pathway for pseudoscience by bundling credible and questionable
therapies together and by encouraging broad integration without a built-in filter for plausibility.[2] Supporters
counter that veterans deserve more toolsparticularly for pain and mental healthand that studying a wider menu is reasonable
as long as the system protects patients from false claims and tracks outcomes.

The VA’s own policy stance suggests it’s aiming for a middle path: expand access to a defined set of generally accepted CIH
practices; keep them adjunctive; require training standards; and maintain the ability to add or remove approaches as evidence
changes.[10]

How to keep “integrative” from becoming “anything goes”

If you want CIH to help veterans without funding pseudoscience, here are the practical rules of the road:

  • Demand condition-specific evidence, not vibe-based marketing. “Helps pain” is not a diagnosis, and “holistic”
    is not a mechanism.
  • Use stepped care. Start with low-risk, evidence-aligned options (movement, sleep support, CBT approaches,
    mindfulness-based interventions) and escalate thoughtfully.
  • Measure outcomes that matter. Pain intensity is one metric, but function, sleep, mood, and quality of life
    often matter moreand can be tracked.
  • Train and credential practitioners. “Certified” should mean trained in a way that stands up to peer review,
    not just membership in a trade association with a nice logo.
  • Be willing to de-adopt. If an intervention doesn’t work in real-world VA settings, or if the benefit is too
    small for the cost, it should be removedno matter how trendy it was on morning TV.

Conclusion

CARA’s push for complementary and integrative health inside veterans’ healthcare is a classic policy trade: it opens doors to
potentially helpful, lower-risk options for pain and mental health, while also creating a wider entrance for therapies that
may be unproven, oversold, or scientifically implausible.[1] The difference between “innovation” and “pseudoscience”
isn’t your brandingit’s your evidence, your outcomes, and your willingness to say “no” when something doesn’t deliver.

The best-case scenario is a VA that uses CARA’s momentum to fund real research, expand access to carefully vetted CIH
services, and give veterans more ways to regain function and quality of lifewithout replacing evidence-based medicine with
wishful thinking. The worst-case scenario is a slow drift toward “anything that feels good must be good,” paid for at scale.
Guardrails decide which future you get.[10]

Postscript: experiences on the ground (what veterans and clinicians often describe)

When people debate “integrative health,” the conversation can get abstract fastpolicy language, evidence grading, and the
eternal tug-of-war between “keep an open mind” and “please keep your mind attached to your brain.” But veterans don’t live in
abstracts. They live in bodies that hurt, nervous systems that stay on high alert, and schedules that don’t always make room
for weekly appointments across town. The experiences below are composite snapshots based on common themes reported in
veterans’ care discussions: what it feels like when CIH is offered well, and what it feels like when it isn’t.

1) The relief of being treated like a whole person. Many veterans describe a moment of surprise when a
clinician asks, “What matters most to you?” instead of launching straight into symptoms. For some, a yoga or tai chi class
isn’t primarily about flexibilityit’s about reclaiming agency. The win isn’t “my pain vanished.” The win is “I slept six
hours,” “I walked the dog,” or “I made it through a crowded grocery store without feeling like my chest was a siren.”
Even modest gains can feel huge when the baseline has been months (or years) of grinding discomfort.

2) Skepticism that melts only when outcomes show up. A common attitude is: “I didn’t join the military to do
breathing exercises.” Fair! Plenty of veterans walk into meditation or guided imagery expecting nonsenseand walk out saying,
“Okay, I hate that this helped.” That kind of reluctant buy-in matters because it’s grounded in lived results. When clinicians
present CIH as an optional tool (not a moral virtue) and set realistic expectations (“this may modestly reduce symptoms and
improve coping”), veterans are more likely to try it without feeling patronized.

3) Frustration when CIH is used as a substitute for real access. The experience flips when CIH feels like a
diversion: “We can’t get you into physical therapy for six weeks, but here’s a handout about mindfulness.” Mind-body tools
can be valuable, but veterans often notice when systems use them to paper over staffing gaps. Integrative care works best when
it’s additivepaired with physical therapy, behavioral health, and medical managementnot when it’s deployed as a budget
Band-Aid.

4) Trust rises when the VA is transparent about evidence. Veterans tend to respond well to straight talk:
“Here’s what we know, here’s what we don’t, and here’s what we’ll track.” When clinicians explain that benefits are usually
modest, that not every approach fits every condition, and that the goal is improved function (not mystical healing),
skepticism becomes collaboration. In contrast, when anyoneVA or outside vendorsclaims a therapy “treats everything,” veterans
often read that as salesmanship, not healthcare.

5) Clinicians describe a practical upside: fewer ‘only two tools’ conversations. Providers working with pain,
trauma, and insomnia often describe the grind of limited options: escalate meds, refer out, repeat. A well-run CIH program can
give clinicians additional off-ramps: massage for muscle tension, biofeedback for autonomic regulation, acupuncture as an
adjunct for certain pain patterns, tai chi/qigong for safe movement, and structured hypnosis or guided imagery for coping and
sleep. The best clinician experiences aren’t about ideology; they’re about having more levers to pull when the usual ones
aren’t enough.

6) The red line veterans often draw: don’t insult our intelligence. Veterans may be open to trying many
thingsespecially low-risk optionsbut they’re quick to reject anything that sounds like magical thinking. The programs that
earn trust tend to be the ones that respect veterans as adults: explain the rationale, encourage questions, and never imply
that pain is “all in your head.” When CIH is delivered with humility and data, it can feel empowering. When it’s delivered
with hype and certainty, it can feel like pseudoscienceno matter how soothing the music is.

The post CARA: Integrating even more pseudoscience into veterans’ healthcare appeared first on Everyday Software, Everyday Joy.

]]>
https://business-service.2software.net/cara-integrating-even-more-pseudoscience-into-veterans-healthcare/feed/0